GROWTH PEP (CJC-1295) is an injectable peptide used to increase GH production. This peptide is a growth hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.

The principal use of GROWTH PEP (CJC-1295) is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including GROWTH PEP (CJC-1295), is chosen as an alternate to using HGH, and only rarely is combined with HGH.

GROWTH PEP (CJC-1295) is in the class of growth hormone releasing hormone (GHRH) mimetics. GHRH is also the name of the naturally-occurring hormone in the body, but the natural compound is not used in bodybuilding or as a performance-enhancing drug due to its high cost of manufacture and its extremely brief duration of action. GROWTH PEP (CJC-1295) is a modified version of the first 29 amino acids of GHRH. The combination of modifications provides a half life of about 1 week, and steady blood levels after injection.

GROWTH PEP (CJC-1295 amplifies GH production in the same way that GHRH does. Administration does not initiate a pulse of GH release. Because GROWTH PEP (CJC-1295) provides steady blood levels, it increases the amplitude of natural GH pulses on an ongoing basis.

Dosage & Use

GROWTH PEP (CJC 1295) is sold in vials containing 2MG of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.

At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example, a 1000 mcg dose would require a volume of 1 mL, or “100 IU” as marked on an insulin syringe.

Injection may be subcutaneous, intramuscular, or intravenous according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe, if there is room. This reduces the total number of injections required.

CJC 1295 NO DAC version should be injected in smaller amounts of 150 micrograms (mcg) 2-3 times per day. Injecting on an empty stomach before breakfast, and then before bed.

Ingredients

GROWTH PEP (CJC-1295): 2mg of C₁₅₂H₂₅₂N₄₄O₄₂

Storage

Below -20 degrees or the freezer. Once reconstituted -8 degrees or the fridge is acceptable.

Medical References

1. Teichman, SL( 1 ), Neale, A( 1 ), Lawrence, B( 2 ), Gagnon, C( 2 ), Castaigne, J-P( 2 ) & Frohman, LA( 3,4 ) n.d., ‘Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults’, Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 799–805
2. Sackmann-Sala, L, Ding, J, Frohman, LA & Kopchick, JJ 2009, ‘Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects’, Growth Hormone & IGF Research, vol. 19, no. 6, pp. 471–477

No statements made on this page have been evaluated by the Bundesministerium für Gesundheit (BMG) or the Therapeutic Goods Administration (TGA). These products are not intended to treat, cure or prevent any disease or illness. All products are strictly for research purposes only. Please refer to the TERMS OF USE for more information.